from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1190/-

LFCtreatmentdescriptionclass of inhibitor

-0.118

Amikacinug/mL Amikacintranslation

-0.202

Cap5-10ug/mL Capreomycintranslation

-0.215

Rox10-50 ug/mL Roxithromycintranslation

-0.394

SM2-5 ug/mL Streptomycintranslation

2.215

Tet5-10 ug/mL Tetracyclinetranslation

0.937

Rif0.2-5ug/mL Rifampicintranscription

0.586

Rifp0.1-0.5ug/mL Rifapentinetranscription

-1.008

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-1.060

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.173

CPZ10-50 ug/mL Chlorpromazinerespiration

-1.735

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.640

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.817

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.781

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.117

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.360

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.000

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.546

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.061

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-1.056

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-1.115

KCN5-20 ug/mL Potassium cyaniderespiration

0.000

NaN30.2-2 mM Sodium aziderespiration

0.549

Nigericin50 uM Nigericinrespiration

0.129

TRC10-150 ug/mL Triclosanrespiration

-0.786

TRZ10-25 ug/mL Thioridazinerespiration

0.425

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

-1.439

menadione6-10 ug/mL Menadionerespiration

0.465

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.194

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.412

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.739

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.987

NRP_1Non-replicating persistence stage 1dosRassociated

-0.194

Amp0.2mg/mL AmpicillincellWall

0.566

Cephalexin20-100 ug/mL CephalexincellWall

0.087

Cerulenin0.32-5 ug/mL CerulenincellWall

0.071

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.114

EMB10-20 ug/mL EthambutolcellWall

-0.126

Eta12-40 ug/mL EthionamidecellWall

-0.164

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.578

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.569

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-1.195

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.211

BZA0.12 mg/mL BenzamidearomaticAmides

-0.159

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.538

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.376

H2O24 mM hydrogen peroxideDNAdamaging

0.224

Levo10 ug/mL LevofloxacinDNAdamaging

-0.133

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.772

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.190

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.541

UVUV-irradiationDNAdamaging

-0.365

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.083

Antimycin12.5-50 ug/mL Antimycin A?

-0.167

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.830

PA_110-50 ug/mL Antitubercular compound PA-1?

0.007

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.113

PA8240.2-2 ug/mL PA-824?

-0.297

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.403

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.355

Verapamil50 uM Verapamil?

-0.003

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.377

methoxatin10-20 ug/mL Methoxatin?